Back
Status filter :


RESET SEARCH AND FILTERS
Malignant disease
Malignant disease / Antibody responsive malignancy
  atezolizumab [Specialist drug] On Formulary NICE TA525
NICE TA739
NICE TA520
NICE TA584
NICE TA705
NICE TA823
NICE TA638
NICE TA639
NICE TA666
  Solution for infusion
Tecentriq (Roche Products Ltd) On Formulary
  bevacizumab [Specialist drug] NICE TA118
NICE TA212
NICE TA242
NICE TA178
NICE TA214
NICE TA263
NICE TA284
NICE TA285
NICE TA666
NICE TA946
  Solution for infusion
Avastin (Roche Products Ltd) Restricted
  brentuximab vedotin [Specialist drug] On Formulary NICE TA478
NICE TA641
NICE TA524
NICE TA577
  cetuximab [Specialist drug] NICE TA145
NICE TA473
NICE TA242
NICE TA439
NICE TA668
  Solution for infusion
Erbitux (Merck Serono Ltd) On Formulary
  obinutuzumab [Specialist drug] NICE TA343
NICE TA513
NICE TA629
  Solution for infusion
Gazyvaro (Roche Products Ltd) On Formulary
  pertuzumab [Specialist drug] NICE TA424
NICE TA509
NICE TA569
  Solution for infusion
Perjeta (Roche Products Ltd) On Formulary
  rituximab NICE TA308
NICE TA195
NICE TA243
NICE TA137
NICE TA193
NICE TA226
NICE TA174
NICE TA359
NICE TA561
  Solution for infusion
Truxima (Celltrion Healthcare UK Ltd) On Formulary
  trastuzumab emtansine [Specialist drug] On Formulary NICE TA458
NICE TA632
Malignant disease / Immunotherapy responsive malignancy
  Bacillus Calmette-GuĂ©rin [Specialist drug] On Formulary
  lenalidomide [Specialist drug] On Formulary NICE TA322
NICE TA171
NICE TA586
NICE TA587
NICE TA627
NICE TA680
  thalidomide [Specialist drug] On Formulary NICE TA228
Malignant disease / Targeted therapy responsive malignancy
  bortezomib [Specialist drug] NICE TA370
NICE TA311
NICE TA228
NICE TA129
  Powder for solution for injection
Velcade (Janssen-Cilag Ltd) Restricted
  palbociclib [Specialist drug] On Formulary NICE TA495
NICE TA836
Malignant disease / Cytotoxic responsive malignancy
  carboplatin [Specialist drug] NICE TA284
NICE TA285
  Solution for infusion
Carboplatin (Non-proprietary) On Formulary
  cisplatin [Specialist drug]
  Solution for infusion
Cisplatin (Non-proprietary) On Formulary
  cladribine NICE TA616
  Solution for injection
Litak (Lipomed GmbH) On Formulary
  Solution for infusion
Leustat (Atnahs Pharma UK Ltd) On Formulary
  cyclophosphamide
  Powder for solution for injection
Cyclophosphamide (Non-proprietary) On Formulary
  cytarabine [Specialist drug]
  Solution for injection
Cytarabine (Non-proprietary) On Formulary
  epirubicin hydrochloride [Specialist drug]
  Solution for infusion
Pharmorubicin (Pfizer Ltd) On Formulary
  eribulin [Specialist drug] NICE TA423
NICE TA515
  Solution for injection
Halaven (Eisai Ltd) On Formulary
  etoposide [Specialist drug]
  Solution for infusion
Etoposide (Non-proprietary) On Formulary
  fluorouracil
  Solution for injection
Fluorouracil (Non-proprietary) On Formulary
  Solution for infusion
Fluorouracil (Non-proprietary) On Formulary
  ifosfamide [Specialist drug]
  Powder for solution for injection
Ifosfamide (Non-proprietary) On Formulary
  methotrexate
  Solution for injection
Methotrexate (Non-proprietary) On Formulary
Metoject PEN (medac UK) On Formulary
  Solution for infusion
Methotrexate (Non-proprietary) On Formulary
  vinblastine sulfate [Specialist drug]
  Solution for injection
Vinblastine sulfate (Non-proprietary) On Formulary
  vincristine sulfate [Specialist drug]
  Solution for injection
Vincristine sulfate (Non-proprietary) On Formulary
Malignant disease / Cytotoxic drug-induced side effects
  folinic acid On Formulary NICE TA212
  mesna On Formulary
Malignant disease / Hyperuricaemia associated with cytotoxic drugs
  allopurinol On Formulary
Malignant disease / Hormone responsive malignancy
  bicalutamide On Formulary
  cyproterone acetate On Formulary
  degarelix NICE TA404
  Powder and solvent for solution for injection
Firmagon (Ferring Pharmaceuticals Ltd) Restricted
  goserelin On Formulary
  lanreotide Restricted
  leuprorelin acetate On Formulary
  Powder and solvent for suspension for injection
Prostap SR DCS (Takeda UK Ltd) On Formulary
  octreotide On Formulary
  Solution for injection
Octreotide (Non-proprietary) On Formulary
Sandostatin (Novartis Pharmaceuticals UK Ltd) On Formulary
  Powder and solvent for suspension for injection
Sandostatin LAR (Novartis Pharmaceuticals UK Ltd) On Formulary
  triptorelin On Formulary
  Powder and solvent for suspension for injection
Decapeptyl SR (Ipsen Ltd) On Formulary
Gonapeptyl Depot (Ferring Pharmaceuticals Ltd) On Formulary
Malignant disease / Hormone responsive breast cancer
  anastrozole On Formulary
  exemestane On Formulary
  fulvestrant On Formulary NICE TA503
  letrozole On Formulary
  tamoxifen On Formulary
  Oral solution
Tamoxifen (Non-proprietary) On Formulary
Malignant disease / Secondary bone metastases and hypercalcaemia
  calcitonin (salmon) On Formulary
  Solution for injection
Calcitonin (salmon) (Non-proprietary) On Formulary
  denosumab On Formulary NICE TA204
NICE TA265
  Solution for injection
Prolia (Amgen Ltd) On Formulary
Xgeva (Amgen Ltd) On Formulary
  pamidronate disodium On Formulary
  Solution for infusion
Pamidronate disodium (Non-proprietary) On Formulary
  sodium clodronate On Formulary
  zoledronic acid Restricted NICE TA464
  Infusion
Aclasta (Sandoz Ltd) Restricted
Zometa (Phoenix Labs Ltd) Restricted